Hiba Ali, Oncology Medical Science Liaison for the Gulf Countries at AstraZeneca, shared a post on LinkedIn:
“Today marks World Breast Cancer Research Day, a moment to honor the relentless progress that is reshaping how we detect, treat, and support patients facing breast cancer!
From imaging innovations to targeted therapies, every breakthrough reflects years of dedication by researchers and advocates who believe in turning science into survival.
One of the most inspiring frontiers is Precision Oncology, with the growing role of AI accelerating discovery and making care smarter and more personalized. Equally transformative are ctDNA technologies, offering the ability to detect resistance earlier and navigate treatment options.
Here’s a powerful read from Springer Nature on how ctDNA is advancing breast cancer research while also reminding us of the equity gaps we must address:
Research is rewriting what’s possible. But its true impact will be measured not just in innovation, but in how widely and equitably its promise is shared reaching every patient, everywhere.”
Title: Bridging the gap: ctDNA, genomics, and equity in breast cancer care
Authors: Julia Aronson, Manasa Bhatta, Lisa Carey, Kunal Jobanputra, Gaorav Gupta, Yara Abdou
You can read the Full Article on Breast Cancer.
More posts featuring Hiba Ali on OncoDaily.